<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T20:41:08Z</responseDate>
  <request identifier="oai:figshare.com:article/33939711" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33939711</identifier>
        <datestamp>2026-09-18T17:51:28Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Demographic, clinical and hematoma specific parameters.&lt;/p&gt;</dc:title>
          <dc:creator>Hussam Hamou (25073553)</dc:creator>
          <dc:creator>Julius Kernbach (25073556)</dc:creator>
          <dc:creator>Hani Ridwan (12119451)</dc:creator>
          <dc:creator>Kimberley Fay-Rodrian (25073559)</dc:creator>
          <dc:creator>Hans Clusmann (721270)</dc:creator>
          <dc:creator>Anke Hoellig (3158208)</dc:creator>
          <dc:creator>Michael Veldeman (3168549)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>validated roc auc</dc:subject>
          <dc:subject>tuning used 10</dc:subject>
          <dc:subject>standard clinical assessment</dc:subject>
          <dc:subject>satisfactory average calibration</dc:subject>
          <dc:subject>regularized logistic regression</dc:subject>
          <dc:subject>outperforming logistic regression</dc:subject>
          <dc:subject>disease severity markers</dc:subject>
          <dc:subject>discriminative capacity insufficient</dc:subject>
          <dc:subject>compared three models</dc:subject>
          <dc:subject>clinically relevant 90</dc:subject>
          <dc:subject>590 &amp;# 8211</dc:subject>
          <dc:subject>5 &amp;# 8211</dc:subject>
          <dc:subject>2015 &amp;# 8211</dc:subject>
          <dc:subject>findings suggest recurrence</dc:subject>
          <dc:subject>risk subgroup suitable</dc:subject>
          <dc:subject>level risk estimates</dc:subject>
          <dc:subject>test performance indicated</dc:subject>
          <dc:subject>driven imaging strategies</dc:subject>
          <dc:subject>calibration slope 0</dc:subject>
          <dc:subject>reducing imaging</dc:subject>
          <dc:subject>recurrence status</dc:subject>
          <dc:subject>recurrence patients</dc:subject>
          <dc:subject>risk patients</dc:subject>
          <dc:subject>risk individuals</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>test set</dc:subject>
          <dc:subject>surgical treatment</dc:subject>
          <dc:subject>supporting uniform</dc:subject>
          <dc:subject>stratified surveillance</dc:subject>
          <dc:subject>sensitivity threshold</dc:subject>
          <dc:subject>roughly one</dc:subject>
          <dc:subject>random forest</dc:subject>
          <dc:subject>radiographic variables</dc:subject>
          <dc:subject>primary outcome</dc:subject>
          <dc:subject>overconfident individual</dc:subject>
          <dc:subject>model development</dc:subject>
          <dc:subject>maintaining monitoring</dc:subject>
          <dc:subject>influential predictors</dc:subject>
          <dc:subject>icu admission</dc:subject>
          <dc:subject>highest cross</dc:subject>
          <dc:subject>hematoma volume</dc:subject>
          <dc:subject>fold cross</dc:subject>
          <dc:subject>escalated surveillance</dc:subject>
          <dc:subject>coagulation parameters</dc:subject>
          <dc:subject>center cohort</dc:subject>
          <dc:subject>best model</dc:subject>
          <dc:subject>772 ),</dc:subject>
          <dc:subject>686 ).</dc:subject>
          <dc:description>&lt;p&gt;Demographic, clinical and hematoma specific parameters.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T17:51:15Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0346756.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Demographic_clinical_and_hematoma_specific_parameters_p_/33939711</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
